You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ER Positive PR Positive Breast Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in São Paulo (radiation, procedure, other)

Recruiting
  • Breast Cancer
  • Radiotherapy
  • +2 more
  • São Paulo, SP, Brazil
    ICESP
Aug 5, 2022

TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Alkaline Glucosodiene Molecules
  • (no location specified)
Jul 14, 2023

Breast Cancer, Brain Metastases Trial in Guangzhou (Palbociclib, Trastuzumab, Pyrotinib and Fulvestrant)

Recruiting
  • Breast Cancer
  • Brain Metastases
  • Palbociclib, Trastuzumab, Pyrotinib and Fulvestrant
  • Guangzhou, Guangdong, China
  • +1 more
Apr 24, 2022

HER2-positive Breast Cancer Trial in China (TQB2440 injection + Trastuzumab + Docetaxel, Perjeta + Trastuzumab + Docetaxel)

Active, not recruiting
  • HER2-positive Breast Cancer
  • TQB2440 injection + Trastuzumab + Docetaxel
  • Perjeta + Trastuzumab + Docetaxel
  • Chongqing, Chongqing, China
  • +5 more
Aug 3, 2023

Breast Cancer, HER2-positive Breast Cancer, ER Positive Breast Cancer Trial (Neratinib, Letrozole (L) or Anastrozole (A),

Not yet recruiting
  • Breast Cancer
  • +3 more
  • (no location specified)
Jan 11, 2022

Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer Trial in Stanford (Infigratinib, Tamoxifen, Omnipaque 350)

Recruiting
  • Breast Cancer
  • +3 more
  • Stanford, California
    Stanford University
Feb 16, 2022

Use of Zoledronic Acid in Breast Cancer Trial in Asyut (Zoledronic Acid 4 MG)

Recruiting
  • Use of Zoledronic Acid in Breast Cancer
  • Zoledronic Acid 4 MG
  • Asyūţ, Asyut, Egypt
    Clinical Oncology Department, Assuit University Hospital
Dec 5, 2021

Stage IV (Metastatic) Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Boston (NERATINIB,

Not yet recruiting
  • Stage IV (Metastatic) Breast Cancer
  • +5 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 25, 2021

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Suspended
  • Anatomic Stage I Breast Cancer AJCC v8
  • +23 more
  • Short-Term Fasting
  • Chemotherapy
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 23, 2023

Metastatic Breast Cancer Trial in Athens

Recruiting
  • Metastatic Breast Cancer
    • Athens, Greece
      Hellenic Society of Medical Oncology
    Feb 9, 2021

    Breast Cancer Trial in United States (bicalutamide, diagnostic laboratory biomarker analysis, immunohistochemistry staining

    Completed
    Has Results
    • Breast Cancer
    • San Francisco, California
    • +7 more
    Jul 8, 2022

    After Neoadjuvant Chemotherapy for Breast Cancer

    Recruiting
    • TN ER-/PR-/HER2- Breast Cancer
    • +3 more
    • Standard Trimodality Breast Imaging
    • Minneapolis, Minnesota
      University of Minnesota Masonic Cancer Center
    Aug 13, 2021

    Breast Cancer, Cancer of the Breast Trial in Saint Louis (VENTANA MIB-1 Ki67 assay, Oncotype DX® Recurrence Score, PAM50-based

    Not yet recruiting
    • Breast Cancer
    • Cancer of the Breast
    • VENTANA MIB-1 Ki67 assay
    • +4 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Apr 18, 2023

    Breast Cancer Stage IV Trial in Irvine (Gallium-68)

    Recruiting
    • Breast Cancer Stage IV
    • Irvine, California
      Hoag Memorial Hospital Presbyterian
    May 26, 2023

    Triple Negative Breast Cancer, HER2-negative Breast Cancer Trial in Tampa (HER2 - primed Dendritic cells, HER3 - primed

    Recruiting
    • Triple Negative Breast Cancer
    • HER2-negative Breast Cancer
    • HER2 - primed Dendritic cells
    • HER3 - primed Dendritic cells
    • Tampa, Florida
      Moffitt Cancer Center
    Jan 10, 2023

    Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)

    Not yet recruiting
    • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
    • (no location specified)
    Sep 26, 2023

    Breast Cancer Trial in Cambridge (Megestrol Acetate 40 MG, Megestrol Acetate 160 MG, Letrozole)

    Unknown status
    • Breast Cancer
    • Megestrol Acetate 40 MG
    • +2 more
    • Cambridge, Cambridgeshire, United Kingdom
      Cambridge University Hospitals NHS Foundation Trust
    Jan 12, 2021

    ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer, a Germline or Somatic BRCA Mutation, or a

    Recruiting
    • ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer
    • a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status
    • Montpellier, France
    • +1 more
    Nov 16, 2022

    Estrogen-receptor-positive Breast Cancer, HER2/Neu-Negative Breast Cancer, Advanced Breast Cancerv Trial in Chicago

    Not yet recruiting
    • Estrogen-receptor-positive Breast Cancer
    • +3 more
    • elacestrant, palbociclib, abemaciclib, ribociclib
    • Chicago, Illinois
      Northwestern University
    Sep 25, 2023

    Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

    Recruiting
    • Hormone Receptor Positive HER-2 Negative Breast Cancer
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jun 12, 2023

    Breast Cancer, Triple Negative Breast Cancer Trial in Gothenburg (Imatinib 400 MG Oral Tablet)

    Not yet recruiting
    • Breast Cancer
    • Triple Negative Breast Cancer
    • Imatinib 400 MG Oral Tablet
    • Gothenburg, Sweden
      Barbro Linderholm
    Feb 1, 2023

    ER-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Cancer Trial in Madison, Milwaukee (Onapristone, Fulvestrant)

    Recruiting
    • ER-positive Breast Cancer
    • +2 more
    • Madison, Wisconsin
    • +1 more
    Jul 7, 2022

    Estrogen Receptor Positive Breast Cancer Trial in Edmonton (Estradiol)

    Active, not recruiting
    • Estrogen Receptor Positive Breast Cancer
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Feb 1, 2023

    Breast Cancer Trial in Sydney ([68Ga]GA-NeoB)

    Recruiting
    • Breast Cancer
    • Sydney, New South Wales, Australia
      St Vincent's Hospital
    May 22, 2023

    Assessed by 18F-FES PET/CT in MBC With ER-positive Primary Tumor

    Recruiting
    • Breast Cancer
      • Shanghai, Shanghai, China
        Biyun Wang, MD
      Apr 5, 2023